- This event has passed.
9th Annual Orphan Drugs and Rare Diseases
October 15 @ 8:30 am - October 16 @ 3:10 pm
The market for rare disease products is continuously growing, expecting to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020).
Given this information, SMi is proud to announce our 9th Annual Orphan Drugs and Rare Diseases conference, aiming to bring together solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders together to discuss possible ways to accelerative orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
- HEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs
- DISCUSS the potential changes in assessing the development of medicines across Europe
- EXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.
- GAIN INSIGHT into the various challenges facing orphan drug development